Literature DB >> 25611215

Iridoid glycosides from Barleria lupulina.

Ki Hyun Kim1, Yong Joo Park, Kyu Hyuck Chung, M L Richard Yip, Jon Clardy, Donald Senger, Shugeng Cao.   

Abstract

Phytochemical investigation of an extract of the aerial part of Barleria lupulina resulted in the identification of four new iridoid glycosides (1-4), together with 14 known analogues (5-18). The structures of 1-4 were determined through 1D and 2D NMR spectroscopic data analysis, HRMS, and acid hydrolysis. This is the first report of iridoid glycosides with a formate group. The free-radical scavenging activity of compounds 9, 12, and 15-17 was assessed using the DPPH assay. Compounds 16 and 17 scavenged DPPH radicals weakly with IC50 values of 97.5 and 78.6 μg/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25611215     DOI: 10.1021/np500791a

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Authors:  Donald R Senger; Mien V Hoang; Ki Hyun Kim; Chunshun Li; Shugeng Cao
Journal:  J Ethnopharmacol       Date:  2016-09-20       Impact factor: 4.360

2.  Chakyunglupulins A and B, two novel 4,8,8-trimethylcyclooct-2-enone derivatives from Barleria lupulina.

Authors:  Ki Hyun Kim; Jon Clardy; Donald Senger; Shugeng Cao
Journal:  Tetrahedron Lett       Date:  2015-05-20       Impact factor: 2.415

3.  Preparative separation of 1,1-diphenyl-2-picrylhydrazyl inhibitors originating from Saxifraga sinomontana employing medium-pressure liquid chromatography in combination with reversed-phase liquid chromatography.

Authors:  Jun Dang; Jianbin Ma; Yangzom Dawa; Chuang Liu; Tengfei Ji; Qilan Wang
Journal:  RSC Adv       Date:  2021-12-02       Impact factor: 4.036

4.  Acthaside: a new chromone derivative from Acacia ataxacantha and its biological activities.

Authors:  Abdou Madjid O Amoussa; Mélanie Bourjot; Latifou Lagnika; Catherine Vonthron-Sénécheau; Ambaliou Sanni
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.